More than 95% of diabetics suffer from type 2 diabetes, which was previously known as non-insulin-dependent or adult-onset diabetes. Historically limited to adults, this form of diabetes is now increasingly affecting younger individuals. This shift highlights a growing health concern, as type 2 diabetes becomes more prevalent among children and adolescents, necessitating greater awareness and preventive measures.

To take care of our health by controlling diabetes is a daily task for an individual. Multiple technologies are available in the market to help control diabetes. One unique product from Novo Nordisk that we should know about is the ‘Dose Check App’. Today, the app is widely used in the Saudi market. With Dose Check, you’ll have your doctor’s guidance at hand to help you get off to a good start on your new basal insulin treatment.

What is Dose Check?

Dose Check is an insulin dose guidance app designed for people with type 2 diabetes who are starting on or switching to selected Novo Nordisk insulins. The app works out your insulin dose for you when you log your fasting blood sugar based on your treatment plan set by your doctor. With your doctor’s guidance at hand, it may help you reach your target dose.

How ‘Dose Check’ works?

Based on your doctor’s treatment plan, Dose Check guides you to your target insulin dose. Your doctor sets up Dose Check online, inputting your treatment details. The app then calculates your required insulin based on your logged blood sugar levels. Each day, Dose Check reminds you to log your fasting blood sugar and administer the recommended insulin dose. This ensures you adhere to your prescribed treatment while enabling your doctor to monitor your progress online.

Using Dose Check Effectively

Take the prescribed dose as directed by your doctor to ensure that you are taking the right amount. Using Dose Check, you will also be able to:

• Check your previous blood sugar levels and insulin doses
• Use the calendar to check you’ve logged your fasting blood sugar level and injected the recommended dose
• View your insulin treatment plan
• See your blood sugar levels and insulin doses in one chart
• Use the charts in the app to check your progress towards reaching your treatment goals
• Receive advice straight away on next steps if you record a blood sugar level that’s too low (hypo)
• Receive tips and insights on managing diabetes

User Reception in Middle East

The Dose Check app has seen a strong and enthusiastic uptake among patients in Saudi Arabia. This is particularly noteworthy as Saudi Arabia is currently the only country in the Middle East where the app is available. Patients in the Kingdom have expressed appreciation for Dose Check’s key features, including its connectivity with glucometers, doctor recommendations, and guidance on hypoglycaemia management.

Don’t Get Duped! WHO Warns of Fake Weight Loss and Diabetes Treatments

A key factor driving the app’s success in Saudi Arabia has been the important role of healthcare professionals. Doctors in the country have been instrumental in recommending and introducing Dose Check to their patients. This has helped ensure a smooth onboarding process, as clinicians provide support during registration and monitor patients’ ongoing progress with the app.

Overall, the reception of Dose Check in the Saudi Arabian market has been extremely positive. Patients have found the app to be a highly valuable tool that addresses key challenges in insulin dose titration, regardless of their individual levels of digital literacy.

Ensuring Data Privacy

The Dose Check application requires access to certain user information to function effectively. It’s important to note that sharing this information for research purposes is entirely voluntary. Users have the right to withdraw their consent at any given time. A simple checkbox allows users to opt in or out of sharing their data with a third party for research purposes.

Also Read: Abbott’s FreeStyle Libre® System & GLP-1 Meds Show Synergistic Impact in Type 2 Diabetes

In the Saudi market, Novo Nordisk Saudi Arabia strictly follows Novo Nordisk’s Data Protection requirements and complies with local guidelines and regulations regarding patient rights and safety. All third parties engaged by the company are required to adhere to these stringent standards, ensuring robust patient protection through comprehensive clauses and annexes incorporated into all agreements.

What Next?

The mobile application has shown promise in empowering patients and facilitating better insulin titration, dosing and blood sugar levels. From the patient’s perspective, the app plays a crucial role in improving patients’ management and outcomes.

Novo Nordisk Saudi Arabia is evaluating digital healthcare resources to facilitate diabetes patient management in the Kingdom of Saudi Arabia.

By the end of 2025, the app is expected to be live in 15-20 markets globally, with support for a range of diabetes brands and integrated devices, including continuous glucose monitoring systems.

The app is designed to be a flexible portfolio offering, with plans to simplify and support both patients and healthcare professionals with medication dosing. By the end of 2025, the app is expected to be live in 15-20 markets globally, with support for a range of diabetes brands and integrated devices, including continuous glucose monitoring systems.

The recent EU Medical Devices Regulation (MDR) approval enables support for additional titration and smart insulin pen features, representing a significant step forward in Novo Nordisk Saudi Arabia’s diabetes therapy strategy and integrated treatment solutions. These advancements demonstrate a strong commitment to enhancing the app and ensuring it remains a leading-edge solution for diabetes management.

Dose Check is an innovative mobile app that aims to empower type 2 diabetes patients, particularly those who are starting basal insulin treatment. The software simplifies insulin titration and maintenance by allowing users to log their blood sugar levels and receive recommended insulin dosages. The app’s popularity in Saudi Arabia indicates the value of digital technologies in diabetes care. Dose Check is on track to become a significant resource for patients and healthcare professionals around the world, with continued growth and expansion plans.